• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

对侧乳腺癌的发生模式和结局:监测、流行病学和最终结果(SEER)数据的分析

Patterns of Occurrence and Outcomes of Contralateral Breast Cancer: Analysis of SEER Data.

作者信息

Xiong Zhenchong, Yang Lin, Deng Guangzheng, Huang Xinjian, Li Xing, Xie Xinhua, Wang Jin, Shuang Zeyu, Wang Xi

机构信息

Department of Breast Surgery, State Key Laboratory of Oncology in Southern China, Collaborative Innovation Center for Cancer Medicine, Sun Yat-sen University Cancer Center, Guangzhou 510030, China.

State Key Laboratory of Oncology in Southern China, Collaborative Innovation Center for Cancer Medicine, Sun Yat-sen University Cancer Center, Guangzhou 510030, China.

出版信息

J Clin Med. 2018 May 31;7(6):133. doi: 10.3390/jcm7060133.

DOI:10.3390/jcm7060133
PMID:29857526
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6025574/
Abstract

Population-based estimates are lacking for the temporal trends in the contralateral breast cancer (CBC) risk for patients with breast cancer (BC). Data for BC patients diagnosed with CBC were collected from the Surveillance, Epidemiology, and End Results database. CBC incidence was calculated using the Kaplan-Meier method and the temporal trend in CBC incidence was assessed using joinpoint regression. Survival analysis was calculated using propensity scoring (PS) and multivariate Cox regression with a competing risk model. We found that 10,944 of 212,630 patients with early-stage BC were subsequently diagnosed with secondary BC in the contralateral breast. The 5-, 10-, 15-, and 20-year cumulative CBC incidences were 1.9, 4.6, 7.6, and 10.5%, respectively. Being younger (.

摘要

目前尚缺乏基于人群的乳腺癌(BC)患者对侧乳腺癌(CBC)风险随时间变化趋势的估计数据。从监测、流行病学和最终结果数据库中收集了诊断为CBC的BC患者的数据。使用Kaplan-Meier方法计算CBC发病率,并使用连接点回归评估CBC发病率的时间趋势。使用倾向评分(PS)和具有竞争风险模型的多变量Cox回归进行生存分析。我们发现,212,630例早期BC患者中有10,944例随后被诊断为对侧乳腺的继发性BC。5年、10年、15年和20年的CBC累积发病率分别为1.9%、4.6%、7.6%和10.5%。年龄较小(.

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8ab1/6025574/2b9e9b28b7d5/jcm-07-00133-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8ab1/6025574/71c4ec343759/jcm-07-00133-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8ab1/6025574/2b9e9b28b7d5/jcm-07-00133-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8ab1/6025574/71c4ec343759/jcm-07-00133-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8ab1/6025574/2b9e9b28b7d5/jcm-07-00133-g002.jpg

相似文献

1
Patterns of Occurrence and Outcomes of Contralateral Breast Cancer: Analysis of SEER Data.对侧乳腺癌的发生模式和结局:监测、流行病学和最终结果(SEER)数据的分析
J Clin Med. 2018 May 31;7(6):133. doi: 10.3390/jcm7060133.
2
A model for individualized risk prediction of contralateral breast cancer.对侧乳腺癌个体化风险预测模型。
Breast Cancer Res Treat. 2017 Jan;161(1):153-160. doi: 10.1007/s10549-016-4039-x. Epub 2016 Nov 4.
3
Preoperative breast magnetic resonance imaging and contralateral breast cancer occurrence among older women with ductal carcinoma in situ.老年原位导管癌女性患者术前乳腺磁共振成像与对侧乳腺癌的发生情况
Breast Cancer Res Treat. 2016 Jul;158(1):139-148. doi: 10.1007/s10549-016-3858-0. Epub 2016 Jun 10.
4
Risk of second primary cancer in the contralateral breast in women treated for early-stage breast cancer: a population-based study.早期乳腺癌女性患者对侧乳房发生第二原发性癌症的风险:一项基于人群的研究。
Int J Radiat Oncol Biol Phys. 2003 Jul 15;56(4):1038-45. doi: 10.1016/s0360-3016(03)00203-7.
5
National trends of synchronous bilateral breast cancer incidence in the United States.美国同步双侧乳腺癌发病率的全国趋势。
Breast Cancer Res Treat. 2019 Nov;178(1):161-167. doi: 10.1007/s10549-019-05363-0. Epub 2019 Jul 19.
6
Survival Outcomes and Pathologic Features Among Breast Cancer Patients Who Have Developed a Contralateral Breast Cancer.患对侧乳腺癌的乳腺癌患者的生存结果和病理特征
Ann Surg Oncol. 2015 Dec;22 Suppl 3:S412-21. doi: 10.1245/s10434-015-4835-2. Epub 2015 Sep 3.
7
The impact of adjuvant therapy on contralateral breast cancer risk and the prognostic significance of contralateral breast cancer: a population based study in the Netherlands.辅助治疗对患侧乳腺癌风险的影响及对侧乳腺癌的预后意义:荷兰一项基于人群的研究
Breast Cancer Res Treat. 2008 Jul;110(1):189-97. doi: 10.1007/s10549-007-9709-2. Epub 2007 Aug 9.
8
Preoperative Breast Magnetic Resonance Imaging and Contralateral Breast Cancer Occurrence Among Older Women With Breast Cancer.老年乳腺癌患者术前乳腺磁共振成像与对侧乳腺癌的发生情况
J Clin Oncol. 2016 Feb 1;34(4):321-8. doi: 10.1200/JCO.2015.62.9741. Epub 2015 Nov 30.
9
Metastatic breast cancer survival improvement restricted by regional disparity: Surveillance, Epidemiology, and End Results and institutional analysis: 1990 to 2011.转移性乳腺癌的生存改善受到地域差异的限制:监测、流行病学和最终结果及机构分析:1990 年至 2011 年。
Cancer. 2020 Jan 15;126(2):390-399. doi: 10.1002/cncr.32531. Epub 2019 Oct 22.
10
The Influence of Adjuvant Systemic Regimens on Contralateral Breast Cancer Risk and Receptor Subtype.辅助全身治疗方案对对侧乳腺癌风险和受体亚型的影响。
J Natl Cancer Inst. 2019 Jul 1;111(7):709-718. doi: 10.1093/jnci/djz010.

引用本文的文献

1
Advancing DIEP Flap Surgery: Robotic-Assisted Harvest Reduces Pain and Narcotic Use.推进腹壁下动脉穿支皮瓣手术:机器人辅助切取皮瓣可减轻疼痛并减少麻醉药物使用。
J Clin Med. 2025 Jul 23;14(15):5204. doi: 10.3390/jcm14155204.
2
Risk factors for second primary breast cancer by laterality, age, and race and ethnicity.按患侧、年龄、种族和族裔划分的第二原发性乳腺癌的风险因素。
J Natl Cancer Inst. 2025 Mar 1;117(3):436-449. doi: 10.1093/jnci/djae254.
3
Second primary cancer risks according to race and ethnicity among U.S. breast cancer survivors.美国乳腺癌幸存者的种族和民族与第二原发癌风险。

本文引用的文献

1
Hormone receptor status of a first primary breast cancer predicts contralateral breast cancer risk in the WECARE study population.在WECARE研究人群中,首次原发性乳腺癌的激素受体状态可预测对侧乳腺癌风险。
Breast Cancer Res. 2017 Jul 19;19(1):83. doi: 10.1186/s13058-017-0874-x.
2
Risks of Breast, Ovarian, and Contralateral Breast Cancer for BRCA1 and BRCA2 Mutation Carriers.BRCA1 和 BRCA2 基因突变携带者的乳腺癌、卵巢癌和对侧乳腺癌风险。
JAMA. 2017 Jun 20;317(23):2402-2416. doi: 10.1001/jama.2017.7112.
3
Alcohol consumption and cigarette smoking in combination: A predictor of contralateral breast cancer risk in the WECARE study.
Int J Cancer. 2024 Sep 15;155(6):996-1006. doi: 10.1002/ijc.34971. Epub 2024 Apr 29.
4
Imaging for local recurrence of breast cancer.乳腺癌局部复发的影像学评估。
J Cancer Res Clin Oncol. 2024 Apr 17;150(4):200. doi: 10.1007/s00432-024-05709-2.
5
Contralateral prophylactic mastectomy in a rural population: A single-institution experience.农村人口的对侧预防性乳房切除术:单机构经验
Surg Open Sci. 2024 Feb 23;18:70-77. doi: 10.1016/j.sopen.2024.02.007. eCollection 2024 Mar.
6
Breast Cancer in the Tissue of the Contralateral Breast Reduction.对侧乳房缩小组织中的乳腺癌
Cancers (Basel). 2024 Jan 24;16(3):497. doi: 10.3390/cancers16030497.
7
Historical trends in breast cancer presentation among women in Pakistan from join-point regression analysis.基于连接点回归分析的巴基斯坦女性乳腺癌发病的历史趋势
Pak J Med Sci. 2024 Jan-Feb;40(1Part-I):134-139. doi: 10.12669/pjms.40.1.7123.
8
Relapse-free survival in Sudanese women with non-metastatic breast cancer.苏丹非转移性乳腺癌女性的无复发生存率。
Glob Epidemiol. 2022 Sep 8;4:100082. doi: 10.1016/j.gloepi.2022.100082. eCollection 2022 Dec.
9
EBCC-13 manifesto: Balancing pros and cons for contralateral prophylactic mastectomy.EBCC-13 宣言:权衡利弊,决定是否行对侧预防性乳房切除术。
Eur J Cancer. 2023 Mar;181:79-91. doi: 10.1016/j.ejca.2022.11.036. Epub 2022 Dec 13.
10
Guidelines for breast cancer management in Bosnia and Herzegovina.波斯尼亚和黑塞哥维那乳腺癌管理指南。
Biomol Biomed. 2023 Feb 1;23(1):2-14. doi: 10.17305/bjbms.2022.7504.
饮酒与吸烟并存:WECARE研究中对侧乳腺癌风险的一个预测因素。
Int J Cancer. 2017 Sep 1;141(5):916-924. doi: 10.1002/ijc.30791. Epub 2017 May 31.
4
Association of Adjuvant Tamoxifen and Aromatase Inhibitor Therapy With Contralateral Breast Cancer Risk Among US Women With Breast Cancer in a General Community Setting.在一般社区环境下,辅助他莫昔芬和芳香酶抑制剂治疗与美国乳腺癌女性对侧乳腺癌风险的关系。
JAMA Oncol. 2017 Feb 9;3(2):186-193. doi: 10.1001/jamaoncol.2016.3340. Epub 2016 Oct 6.
5
Systemic therapy for breast cancer and risk of subsequent contralateral breast cancer in the WECARE Study.WECARE研究中乳腺癌的全身治疗与后续对侧乳腺癌风险
Breast Cancer Res. 2016 Jul 12;18(1):65. doi: 10.1186/s13058-016-0726-0.
6
Extending Aromatase-Inhibitor Adjuvant Therapy to 10 Years.将芳香化酶抑制剂辅助治疗延长至10年。
N Engl J Med. 2016 Jul 21;375(3):209-19. doi: 10.1056/NEJMoa1604700. Epub 2016 Jun 5.
7
BRCA1 and BRCA2 Mutation Testing in Young Women With Breast Cancer.BRCA1 和 BRCA2 基因突变检测在年轻乳腺癌女性中的应用。
JAMA Oncol. 2016 Jun 1;2(6):730-6. doi: 10.1001/jamaoncol.2015.5941.
8
Anastrozole versus tamoxifen for the prevention of locoregional and contralateral breast cancer in postmenopausal women with locally excised ductal carcinoma in situ (IBIS-II DCIS): a double-blind, randomised controlled trial.阿那曲唑与他莫昔芬预防局部切除原位导管癌的绝经后妇女局部及对侧乳腺癌(IBIS-II DCIS):一项双盲、随机对照试验
Lancet. 2016 Feb 27;387(10021):866-73. doi: 10.1016/S0140-6736(15)01129-0. Epub 2015 Dec 11.
9
American Cancer Society/American Society of Clinical Oncology Breast Cancer Survivorship Care Guideline.美国癌症协会/美国临床肿瘤学会乳腺癌生存者护理指南。
CA Cancer J Clin. 2016 Jan-Feb;66(1):43-73. doi: 10.3322/caac.21319. Epub 2015 Dec 7.
10
Survival Outcomes and Pathologic Features Among Breast Cancer Patients Who Have Developed a Contralateral Breast Cancer.患对侧乳腺癌的乳腺癌患者的生存结果和病理特征
Ann Surg Oncol. 2015 Dec;22 Suppl 3:S412-21. doi: 10.1245/s10434-015-4835-2. Epub 2015 Sep 3.